Search

everythinglearnresearchcommunity

for

Search:↓

Cyclophosphamide helped 59.4% of children with steroid-resistant nephrotic syndrome but caused side effects in 40.6%.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Oral minoxidil is as effective and safe as topical minoxidil for treating female pattern hair loss.

Some dibenzo compounds might help treat cancer with fewer side effects.

The new gel for psoriasis is effective, stable, and easy to apply.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

Nitroglycerin ointment is now used to treat several skin conditions with fewer side effects.

Modified HDL can better deliver drugs and genes, potentially improving treatments and reducing side effects.

The model and estimator can predict drug exposure in kidney transplant patients well.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

Isotretinoin and tazarotene help treat acne, while minoxidil and finasteride promote hair growth.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

New methods may speed up drug development for male subfertility.

Peptide-based PROTACs show promise in targeting hard-to-treat proteins, especially for cancer therapy.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

Modifying steroidal inhibitors shows promise for developing new cancer treatments.

The article concludes that a balance is needed between individual healthcare needs and societal resources when it comes to lifestyle drugs, with a call for compassionate policy application.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

New methods are being developed to improve drug delivery to the brain.

New drugs and combination therapies are improving treatment for lower urinary tract symptoms.

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

The lecture concluded that drugs for human enhancement are here to stay and called for their responsible development and fair access.

Finasteride, a drug, can block the seizure-preventing effects of a hormone called progesterone in mice.